Search Result "ASCT"
The Role of Stem Cell Transplantation in Multiple Myeloma
Ebook: Multiple Myeloma - A New Era of Treatment Strategies
Volume: 1 Year: 2012
Author(s): Jean-Luc Harousseau
Doi: 10.2174/978160805297411201010088
Stem Cell Transplantation in Multiple Myeloma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 9 Year: 2017 Page: 769-781
Author(s): Massimo Offidani,Silvia Gentili,Francesca Gay,Elena Aghemo,Laura Maracci,Laura Corvatta,Antonio Palumbo
Use of Radioimmunotherapy in Stem Cell Transplantation and Posttransplantation: Focus on Yttrium 90 Ibritumomab Tiuxetan
Journal: Current Stem Cell Research & Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 239-248
Author(s): Arturo Molina, Amrita Krishnan, Henry Fung, Ian W. Flinn, David Inwards, Jane N. Winter, Auayporn Nademanee
Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
Journal: Current Cancer Drug Targets
Volume: 12 Issue: 7 Year: 2012 Page: 743-756
Author(s): Fortunato Morabito,Anna Grazia Recchia,Carla Mazzone,Massimo Gentile
Autologus Stem Cell Transplatation as a Care Option in Elderly Patients. A Review
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 9 Year: 2013 Page: 1419-1429
Author(s): Lucia Fratino, Maurizio Rupolo, Mario Mazzuccato, Massimiliano Berretta, Arben Lleshi, Umberto Tirelli, Mariagrazia Michieli
Immunomodulatory Drugs (IMiDs) in Multiple Myeloma
Journal: Current Cancer Drug Targets
Volume: 17 Issue: 9 Year: 2017 Page: 846-857
Author(s): Shahzad Raza,Rachael A. Safyan,Suzanne Lentzsch
Role of MIF-173G/C and Mbl2 Codon 54A/B Variants in the Risk of Multiple Myeloma: An Association Study
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 21 Issue: 5 Year: 2021 Page: 925-931
Author(s): Mustafa Pehlivan,Ayşe F. Nursal,İlknur Gündeş,Yasemin Oyacı,Demet Kıvanç,Sacide Pehlivan
What is the Best Option to Cure Patients with Resistant/Relapsing Hodgkins Disease?
Journal: Current Stem Cell Research & Therapy
Volume: 1 Issue: 3 Year: 2006 Page: 419-424
Author(s): Massimo Magagnoli, Monica Balzarotti, Luca Castagna, Monica Demarco, Armando Santoro
Aberrant Immunoglobulin Variations as Indicators of Eventual Clonal Changes in Symptomatic Multiple Myeloma Patients' Course
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 2 Year: 2014 Page: 90-96
Author(s): Eftychia Nikolaou,Efstathios Koulieris,Dimitrios Maltezas,Aikaterini Sarris,Theodoros Iliakis,Nora-Athina Vyniou,Ioanna Vardounioti,Vasiliki Karali,Ilias Pessach,Anna Efthymiou,Aikaterini Bitsani,Vasiliki Bartzis,Tatiana Tzenou,Maria Dimou,Theodoros P. Vassilakopoulos,Maria M. Angelopoulou,Panagiotis Tsaftaridis,Kalliroi Tsalimalma,Nikolitsa Kafasi,Panayiotis Panayiotidis,Marie-Christine Kyrtsonis
Guideline to Multiple Myeloma Treatment Strategies
Ebook: Multiple Myeloma - A New Era of Treatment Strategies
Volume: 1 Year: 2012
Author(s): Klaus Podar,Jonathan L. Kaufmann,Jacob P. Laubach,Sagar Lonial,Paul G. Richardson,Kenneth C. Anderson
Doi: 10.2174/978160805297411201010073